1.
Early and Maintained Response Levels in Psoriasis Patients Treated with Tildrakizumab. J of Skin [Internet]. 2020 Sep. 2 [cited 2025 Apr. 18];4(5):s41. Available from: https://skin.dermsquared.com/skin/article/view/990